Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov;102(5):379-390.
doi: 10.1111/cge.14198. Epub 2022 Aug 16.

HINT1 neuropathy: Expanding the genotype and phenotype spectrum

Affiliations
Review

HINT1 neuropathy: Expanding the genotype and phenotype spectrum

Victor Morel et al. Clin Genet. 2022 Nov.

Abstract

Inherited peripheral neuropathy (IPN) is a heterogeneous group of disorders due to pathogenic variation in more than 100 genes. In 2012, the first cases of IPN associated with HINT1 pathogenic variations were described in 33 families sharing the same phenotype characterized by an axonal neuropathy with neuromyotonia and autosomal recessive inheritance (NMAN: OMIM #137200). Histidine Triad Nucleotide Binding Protein 1 regulates transcription, cell-cycle control, and is possibly involved in neuropsychiatric pathophysiology. Herein, we report seven French patients with NMAN identified by Next Generation Sequencing. We conducted a literature review and compared phenotypic and genotypic features with our cohort. We identified a new HINT1 pathogenic variation involved in NMAN: c.310G>C p.(Gly104Arg). This cohort is comparable with literature data regarding age of onset (7,4yo), neuronal involvement (sensorimotor 3/7 and motor pure 4/7), and skeletal abnormalities (scoliosis 3/7, feet anomalies 6/7). We expand the phenotypic spectrum of HINT1-related neuropathy by describing neurodevelopmental or psychiatric features in six out of seven individuals such as generalized anxiety disorder (GAD), obsessive-compulsive disorder (OCD), mood disorder and attention deficit hyperactivity disorder (ADHD). However, only 3/128 previously described patients had neuropsychiatric symptomatology or neurodevelopmental disorder. These features could be part of HINT1-related disease, and we should further study the clinical phenotype of the patients.

Keywords: ARAN-NM; Charcot-Marie-tooth disease; France; HINT1; NMAN; Neuromyotonia; Peripheral neuropathy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interest.

Figures

FIGURE 1
FIGURE 1
Schematic illustration of HINT1 protein and mutations [Colour figure can be viewed at wileyonlinelibrary.com]
FIGURE 2
FIGURE 2
(A) Geographic distribution of published HINT1 pathogenic mutations. (B) HINT1 pathogenic mutations and their publications [Colour figure can be viewed at wileyonlinelibrary.com]

References

    1. Benquey T, Pion E, Cossée M, et al. A National French Consensus on gene list for the diagnosis of Charcot‐Marie‐tooth disease and related disorders using next‐generation sequencing. Genes. 2022;13(2). doi:10.3390/genes13020318 - DOI - PMC - PubMed
    1. Zimoń M, Baets J, Almeida‐Souza L, et al. Loss‐of‐function mutations in HINT1 cause axonal neuropathy with neuromyotonia. Nat Genet. 2012;44(10):1080‐1083. doi:10.1038/ng.2406 - DOI - PubMed
    1. Weiske J, Huber O. The histidine triad protein Hint1 triggers apoptosis independent of its enzymatic activity. J Biol Chem. 2006;281(37):27356‐27366. doi:10.1074/jbc.M513452200 - DOI - PubMed
    1. Zambelli D, Zuntini M, Nardi F, et al. Biological indicators of prognosis in Ewing's sarcoma: an emerging role for lectin galactoside‐binding soluble 3 binding protein (LGALS3BP). Int J Cancer. 2010;126(1):41‐52. doi:10.1002/ijc.24670 - DOI - PubMed
    1. Schöler J, Ferralli J, Thiry S, Chiquet‐Ehrismann R. The intracellular domain of teneurin‐1 induces the activity of microphthalmia‐associated transcription factor (MITF) by binding to transcriptional repressor HINT1. J Biol Chem. 2015;290(13):8154‐8165. doi:10.1074/jbc.M114.615922 - DOI - PMC - PubMed

Supplementary concepts